|
"wu hc"的相關文件
顯示項目 81-90 / 241 (共25頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目
| 臺北醫學大學 |
2014 |
Podocalyxin-like 1 promotes invadopodia formation and metastasis through activation of Rac1/Cdc42/cortactin signaling in breast cancer cells
|
Lin, CW;Sun, MS;Liao, MY;Chung, CC;Chi, YH;Chiou, LT;Yu, J;Lou, KL;Wu, HC |
| 臺北醫學大學 |
2014 |
Role of a Janus kinase 2-dependent signaling pathway in platelet activation
|
Lu, WR;Lin, KC;Huang, SY;Aloysi, Thomas Philip;Wu, YU;Wu, HC;Lin, KH;Sheu, JR |
| 國家衛生研究院 |
2013-11 |
Peptide-mediated liposomal doxorubicin enhances drug delivery efficiency and therapeutic efficacy in lung cancer animal models
|
Wu, HC;Chang, DK;Li, PC;Hsieh, HP |
| 國家衛生研究院 |
2013-11 |
Hepatitis B virus pre-S2 mutant stimulates aerobic glycolysis through mammalian target of rapamycin signaling in tumorigenesis
|
Teng, CF;Wu, HC;Hsieh, WC;Tsai, HW;Su, IJ |
| 國家衛生研究院 |
2013-07 |
Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma
|
Chung, KM;Chang, ST;Huang, WT;Lu, CL;Wu, HC;Hwang, WS;Chang, KY;Chuang, SS |
| 國家衛生研究院 |
2013-07 |
Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: A randomized controlled trial
|
Chi, CY;Khanh, TH;Thoa, LP;Tseng, FC;Wang, SM;Thinh, LQ;Lin, CC;Wu, HC;Wang, JR;Hung, NT;Thuong, TC;Chang, CM;Su, IJ;Liu, CC |
| 國家衛生研究院 |
2013-06-27 |
Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;Chang, JY |
| 國家衛生研究院 |
2013-02-26 |
Injectable and thermoresponsive self-assembled nanocomposite hydrogel for long-term anticancer drug delivery
|
Chen, YY;Wu, HC;Sun, JS;Dong, GC;Wang, TW |
| 國家衛生研究院 |
2013-02 |
Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients
|
Hsieh, YH;Su, IJ;Yen, CJ;Tsai, TF;Tsai, HW;Tsai, HN;Huang, YJ;Chen, YY;Ai, YL;Kao, LY;Hsieh, WC;Wu, HC;Huang, W |
| 國家衛生研究院 |
2013-02 |
Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis B virus infection
|
Su, IJ;Hsieh, WC;Tsai, HW;Wu, HC |
顯示項目 81-90 / 241 (共25頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目
|
